Association between relative hypogonadism and metabolic syndrome in newly diagnosed adult male patients with impaired glucose tolerance or type 2 diabetes mellitus

Metabolic Syndrome and Related Disorders

Volumn 2, Issue 1, 2004, Pages 39-48

  Zou, Buhao ^a   Sasaki, Haruka ^b   Kumagai, Shuzo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GLUCOSE; LIPID; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; GENDER; GLUCOSE METABOLISM; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADISM; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; JAPAN; LIPID METABOLISM; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; SUBCUTANEOUS FAT; TESTOSTERONE BLOOD LEVEL;

EID: 5044250277     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2004.2.39     Document Type: Article

References (75)

1. Lebovitz HE. The relationship of obesity to the metabolic syndrome. Int J Clin Pract Suppl 2003;134:18-27.
2. Nagaretani H, Nakamura T, Funahashi T, et al. Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance. Diabetes Care 2001;24:2127-2133.
3. Whaley MH, Kampert JB, Kohl HW III, et al. Physical fitness and clustering of risk factors associated with the metabolic syndrome. Med Sci Sports Exerc 1999;31:287-293.
4. Carroll S, Cooke CB, Butterly RJ. Metabolic clustering, physical activity and fitness in nonsmoking, middle-aged men. Med Sci Sports Exerc 2000;32: 2079-2086.
5. Zhao SP, Li XP. The association of low plasma testosterone level with coronary artery disease in Chinese men. Int J Cardiol 1998;63:161-164.
6. Alexandersen P, Haarbo J, Christiansen C. The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 1996;125:1-13.
7. Nagano M, Kai Y, Zou B, et al. The contribution of cardiorespiratory fitness and visceral fat to the risk factors in the Japanese patients with impaired glucose tolerance and type 2 diabetes mellitus. Metabolism 2004;53:644-649.
8. Kai Y, Nagano M, Zou B, et al. Relative contribution of fitness and fatness on metabolic syndrome in Japanese patients with type 2 diabetes mellitus. Med Sci Sports Exerc 2004;36:S84-S85.
9. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
10. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-1520.
11. Alberti KGMM, Zimmet PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
12. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
13. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiological perspective. Epidemiol Rev 1998;20:157-172.
14. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
15. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes in mortality results. JAMA 1982;248: 1465-1470.
16. Castelli WP. Lipids, risk factors and ischemic heart disease. Atherosclerosis 1996;s124:S1-S9.
17. European Atherosclerosis Society Study Group. The recognition and management of hyperlipidaemia in adults: a policy statement of the European Atherosclerosis Society. Eur Heart J 1988;9:571-600.
18. Barrett-Connor E, Khaw KT, Yen SSC. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol 1990;132:895-901.
19. Barrett-Connor E. Lower enodgenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med 1992;117:807-811.
20. Andersson B, Mårin P, Lissner L, et al. Testosterone concentrations in women and men with NIDDM. Diabetes Care 1994;17:405-411.
21. Haffner SM, Shaten J, Stern MP, et al. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. Am J Epidemiol 1996;143:889-897.
22. Hak AE, Witteman JC, de Jong FH, et al. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam Study. J Clin Endocrinol Metab 2002;87:3632-3639.
23. Ducimetiere P, Eschwege E, Papoz L, et al. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle aged population. Diabetologia 1980;19:205-210.
24. Simon D, Charles MA, Nahoul K, et al. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: the Telecom Study. J Clin Endocrinol Metab 1997;82:682-685.
25. Haffner S, Karhapää F, Mykkänen L, et al. Insulin resistance, body fat distribution and sex hormones in men. Diabetes 1994;43:212-219.
26. Abate N, Garg A, Peshock RM, et al. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 1996;45:1684-1693.
27. Abate N, Garg A, Peshock RM, et al. Relationships of generalized and regional adiposity to insulin sensitivity. J Clin Invest 1995;96:88-98.
28. Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med 1985;103:983-988.
29. Holmäng A, Bjärntorp P. The effects of testosterone on insulin sensitivity in male rats. Acta Physiol Scand 1992;146:505-510.
30. Mårin P, Holmäng S, Jonsson L, et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 1992;16:991-997.
31. Phillis GB. Relationship between serum sex hormones and glucose, insulin and lipid abnormalities in men with myocardial infarction. Proc Natl Acad Sci USA 1977;74:1729-1733.
32. Birkeland K, Hanssen KF, Torjesen PA, et al. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab 1993;76:275-278.
33. Haffner S, Valdez RA, Mykkänen L, et al. Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism 1994;43:599-603.
34. Phillips GB. Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity. Metabolism 1993;42:116-120.
35. Simon D, Preziosi P, Barrett-Connor E, et al. Interrelation between plasma testosterone and plasma insulin in healthy adult men: the telecom study. Diabetologia 1992;35:173-177.
36. Pasquali R, Casimirri F, Cantebelli S, et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 1991;40:101-104.
37. Fukui M, Koyama M, Nakagawa Y, et al. Castration and diabetes. Diabetes Care 2000;23:1032-1033.
38. Stellato RK, Feldman HA, Hamdy O, et al. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men. Diabetes Care 2000;23:490-494.
39. Laaksonen DE, Niskanen L, Punnonen K, et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003;149:601-608.
40. Tokunaga K, Matsuzawa Y, Ishikawa K, et al. A novel technique for the determination of body fat by computed tomography. Int J Obesity 1983;7:437-445.
41. Astrand PO, Rhyming I. A nomogram for calculation of the aerobic capacity (physical fitness) from pulse rate during submaximal work. J Appl Physiol 1954;7: 218-221.
42. Howard G, Bergman R, Wagenknecht LE, et al. Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "Minimal Model." Ann Epidemiol 1998;8:358-369.
43. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000;85:4426-4433.
44. Haffner SM, Shaten J, Stern MP, et al. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men: MRFIT Research Group Multiple Risk Factor Intervention Trial. Am J Epidemiol 1996;143: 889-897.
45. Stellato RK, Feldman HA, Hamdy O, et al. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 2000;23:490-494.
46. Iverius PH, Brunzell JD. Relationship between lipoprotein lipase activity and plasma steroid level in obese women. J Clin Invest 1988;82:1106-1112.
47. Sorva R, Kuusi T, Taskinen MR, et al. Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males. Atherosclerosis 1988;69:191-197.
48. Mårin P, Krotkiewski M, Björntorp P. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur J Med 1992;1:329-336.
49. Mårin P, Holmäng S, Jonsson L, et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 1992;16:991-997.
50. Mårin P. Testosterone and regional fat distribution. Obes Res 1995;3:609S-612S.
51. Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci 2002;102:151-166.
52. McCarty MF. Modulation of adipocyte lipoprotein lipase expression as a strategy for preventing or treating visceral obesity. Med Hypoth 2001;57:192-200.
53. Staessen J, Bulpitt CJ, Fagard R, et al. The influence of menopause on blood pressure. J Hum Hypertens 1989;3:427-433.
54. Weiss NS. Relationship of menopause to serum cholesterol and arterial pressure: The United States Health Examination Survey of Adults. Am J Epidemiol 1972;96:237-241.
55. Staessen JA, Ginnochio G, Thijs L, et al. Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens 1997;11:507-514.
56. Regensteiner JG, Hiatt WR, Byyny RL, et al. Short-term effects of estrogen and progestin on blood pressure of normotensive postmenopausal women. J Clin Pharmacol 1991;31:543-548.
57. Szekacs B, Vajo Z, Acs N, et al. Hormone replacement therapy reduces mean 24-hour blood pressure and its variability in postmenopausal women with treated hypertension. Menopause 2000;7:31-35.
58. Pripp U, Hall G, Csemiczky G, et al. A randomized trial on effects of hormone replacement therapy on ambulatory blood pressure and lipoprotein levels in women with coronary artery disease. J Hypertens 1999;17:1379-1386.
59. Manwaring P, Morfis L, Diamond T, et al. Effects of hormone replacement therapy on ambulatory blood pressure responses in normotensive women. Blood Press 2000;9:22-27.
60. Akkad AA, Halligan AWF, Abrams K, et al. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy. Obstet Gynecol 1997;89:97-103.
61. Seely EW, Walsh BW, Gerhard MD, et al. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension 1999;33:1190-1194.
62. Manhem K, Ahlm H, Milsom I, et al. Transdermal oestrogen reduces daytime blood pressure in hypertensive women. J Hum Hypertens 1998;12:323-327.
63. Lind T, Cameron EC, Hunter WM, et al. A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br J Obstet Gynaecol 1979;86:1-29.
64. Phillips GB, Jing TY, Resnick LM, et al. Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension. J Hypertens 1993;11:699-702.
65. Jaffe A, Chen Y, Kisch ES, et al. Erectile dysfunction in hypertensive subjects. Assessment of potential determinants. Hypertension 1996;28:859-862.
66. Hughes GS, Mathur RS, Margolius HS. Sex steroid hormones are altered in essential hypertension. J Hypertens 1989;7:181-187.
67. Giltay EJ, Hoogeveen EK, Elbers JM, et al. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab 1998;83:550-553.
68. Kumai T, Tanaka M, Watanabe M, et al. Possible involvement of androgen in increased norepinephrine synthesis in blood vessels of spontaneously hypertensive rats. Jpn J Pharmacol 1994;66:439-444.
69. Yang XC, Jing TY, Resnick LM, et al. Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormones in men. Arterioscler Thromb 1993;13:467-471.
70. Phillips GB, Jing T, Heymsfield SB. Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction. Metabolism 2003;52: 784-790.
71. Phillips GB, Pinkernell BH, Jing TY. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb 1994;14:701-706.
72. Rosner W. An extraordinarily inaccurate assay for free testosterone is still with us. J Clin Endocrinol Metab 2001;86:2903.
73. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
74. Morley JE, Patrick P, Perry HM III. Evaluation of assays available to measure free testosterone. Metabolism 2002;51:554-559.
75. Matsumoto AM, Bremner WJ. Serum testosterone assays-accuracy matters. J Clin Endocrinol Metab 2004; 89:520-524.